Swedish Orphan Biovitrum AS, also known as Sobi, is a pharmaceutical company specializing in rare diseases. The company focuses on the development of innovative treatments, particularly in hematology and immunology. Through its work, Sobi offers treatments for several rare diagnoses, with the aim of improving the quality of life for patients.
Sobi is engaged in collaboration with patient organizations and has a sustainable approach to health and treatment. The company also develops programs that promote physical activity and quality of life for patients, as well as offering resources and support for relatives. This commitment reflects a holistic approach to patient care and support.